Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
InSightec
Medical College of Wisconsin
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Maastricht Radiation Oncology
Thomas Jefferson University
Sunnybrook Health Sciences Centre
Universitat Politècnica de València
Universitat Politècnica de València
Universitat Politècnica de València
Wayne State University
Centre Georges Francois Leclerc
Taproot Health
Hospital del Rio Hortega
Novosibirsk State University
Lanzhou University Second Hospital
Hopital Nord Franche-Comte
Sichuan University
University of Manitoba
Asan Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Istituto Oncologico Veneto IRCCS
University of California, San Francisco
Hospital del Rio Hortega
University of Nebraska
Henry Ford Health System
Beijing Sanbo Brain Hospital
University of Ulm
Karolinska University Hospital
University of Erlangen-NĂźrnberg Medical School
University of Iowa
Brighton and Sussex University Hospitals NHS Trust
Massachusetts General Hospital
University Hospital Regensburg
Duke University
Allina Health System
Egyptian Medical Syndicate
Case Comprehensive Cancer Center
Centre Hospitalier Universitaire, Amiens
Sheri Kashmir Institute of Medical Sciences
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
University of California, San Francisco
Swiss Cancer Institute
Technische Universität Dresden
Alliance for Clinical Trials in Oncology
Eisai Inc.
Maastricht Radiation Oncology
Assistance Publique - HĂ´pitaux de Paris
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine